Sedia Biosciences (India) Private Limited
About Sedia Biosciences (India) Private Limited
Data last updated:
Sedia Biosciences (India) Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 23 November 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33111MH2022FTC394041. Its GSTIN is 27ABJCS7948C1ZY (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹15 Lakh. It is led by directors including Ronald William Mink (Whole-Time Director) and Roger Ian Gale (Whole-Time Director).
Its last annual general meeting (AGM) was held on 15 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D1 Krishna Complex Subhash Road Vile Parle East, Mumbai, Maharashtra, India – 400057.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.62 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹13.33 Lakh (net margin 5.1%) and EBITDA of ₹15.73 Lakh (EBITDA margin 6%).
The company has about 5 employees on its provident fund (EPFO) records.
Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sedia Biosciences (India) Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD1 Krishna Complex Subhash Road Vile Parle East, Mumbai, Maharashtra, India – 400057
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Sedia Biosciences (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Sedia Biosciences (India) are trade and professional, scientific and technical. In detail, this covers retail trading and other professional, scientific and technical activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | |
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Sedia Biosciences (India) Private Limited, buy the company report.
Financials of Sedia Biosciences (India) Private Limited
FY 2025 filings availableSedia Biosciences (India) Private Limited reported revenue of ₹2.62 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 3% in the latest year. EBITDA fell 58% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹15.73 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹13.33 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 6% | ||
| Net Profit Margin | 5.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Sedia Biosciences (India) Private Limited, buy the company report.
Board of directors of Sedia Biosciences (India) Private Limited
Sedia Biosciences (India) has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ronald William Mink | Whole-Time Director | 23 Nov 2022 | 3 Years 11 Months | Current |
| Roger Ian Gale | Whole-Time Director | 23 Nov 2022 | 3 Years 11 Months | Current |
| Sujata Mital Rajindar Also directs: Inditalia Refcon Ltd, Sumit Biosciences Private Limited | Director | 23 Nov 2022 | 3 Years 11 Months | Current |
Peer comparison
Sedia Biosciences (India) Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Biosciences, Healthcare Equipment Retail and Distribution), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ingram Biosciences Private Limited | ₹2.62 Cr (FY 2024) | 115.0% | Noida, Uttar Pradesh, India | |||
| Sedia Biosciences (India) Private Limitedthis company | ₹2.62 Cr (FY 2025) | ₹13.33 Lakh | 5.1% | 3.0% | 5 | Mumbai, Maharashtra, India |
| Acmecs Healthcare Private Limited | ₹2.62 Cr (FY 2024) | Madurai, Tamil Nadu, India | ||||
| VFL Sciences Private Limited | ₹2.62 Cr (FY 2025) | 253.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Sedia Biosciences (India) Private Limited, buy the company report.
Auditor
Sedia Biosciences (India) Private Limited is audited by V.S.Patangia& Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V.S.Patangia& Co. | FY 2023 | 107626W |
Shareholding
The shareholding of Sedia Biosciences (India) Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Sedia Biosciences (India) Private Limited, buy the company report.
Legal cases
Sedia Biosciences (India) Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (CARBP) | Filed against the company by Viatris Healthcare Pty Ltd | Disposed |
To see the full case history of Sedia Biosciences (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sedia Biosciences (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sedia Biosciences (India) Private Limited has a workforce of 5 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 5 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 |
To see the full employee and EPFO history of Sedia Biosciences (India) Private Limited, buy the company report.
GST
Sedia Biosciences (India) has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABJCS7948C1ZY | Maharashtra | Active | 19 Jun 2023 |
| 29ABJCS7948C1ZU | Karnataka | Active | 10 Apr 2023 |
To see the full GST registrations and return filing status of Sedia Biosciences (India) Private Limited, buy the company report.
Recent activity
Sedia Biosciences (India) Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Roger Ian Gale was appointed as Whole-Time Director on 23 Nov 2022.
Frequently asked questions
Sedia Biosciences (India) is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 23 November 2022 (4+ years old) and is registered under CIN U33111MH2022FTC394041.
Sedia Biosciences (India) has 3 current directors:
- Ronald William Mink - Whole-Time Director
- Roger Ian Gale - Whole-Time Director
- Sujata Mital Rajindar - Director
The latest financial statements of Sedia Biosciences (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 15 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Sedia Biosciences (India) is 27ABJCS7948C1ZY, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 29ABJCS7948C1ZU (Karnataka).
The CIN (Corporate Identification Number) of Sedia Biosciences (India) is U33111MH2022FTC394041. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sedia Biosciences (India) has 1 court case on record: 1 filed against it.
Sedia Biosciences (India) was incorporated on 23 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Sedia Biosciences (India) by revenue are Ingram Biosciences Private Limited, Acmecs Healthcare Private Limited, VFL Sciences Private Limited, all in the Healthcare industry (Biosciences, Healthcare Equipment Retail and Distribution), with the same principal business activity (retail trading).
Roger Ian Gale was appointed as Whole-Time Director on 23 Nov 2022. Ronald William Mink was appointed as Whole-Time Director on 23 Nov 2022. Sujata Mital Rajindar was appointed as Director on 23 Nov 2022.
The registered office of Sedia Biosciences (India) is at D1 Krishna Complex Subhash Road Vile Parle East, Mumbai, Maharashtra, India – 400057.
Sedia Biosciences (India) operates in the healthcare industry, in the medical equipment retail and distribution segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
